Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J v. Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

Stent patent infringement award of $324.4 mil. to Johnson & Johnson is set aside and a new damages trial has been ordered in Wilmington federal court, Boston Scientific announces March 28. However, the court upheld a portion of a December 2000 jury verdict that found the NIR stent, made by Medinol for Boston Scientific, infringed one claim of J&J's '762 Palmaz balloon expandable stent patent (1"The Gray Sheet" Dec. 18, 2000, p. 16). "Regardless of the outcome of the new damages trial, we plan on appealing any infringement judgment entered," Boston Scientific says...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel